Praxis Precision Medicines has been granted a patent for fused heteroaryl compounds to treat diseases related to abnormal sodium ion channel function, including epilepsy and neurological disorders. The method involves administering specific compounds to patients suffering from these conditions. GlobalData’s report on Praxis Precision Medicines gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Praxis Precision Medicines, Peptide pharmacophores was a key innovation area identified from patents. Praxis Precision Medicines's grant share as of February 2024 was 14%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11918571B2) discloses a method for treating neurological disorders, specifically focusing on epilepsy and epilepsy syndromes. The method involves administering a compound of Formula (I) to individuals in need of treatment. The patent outlines various specific embodiments and variations within the method, including the use of different compounds, such as those with pyridyl or phenyl groups, and different alkyl or alkyl-substituted groups.
Furthermore, the patent claims cover a range of neurological disorders, including epileptic encephalopathies like Dravet syndrome, infantile spasms, and Lennox-Gastaut syndrome. It also extends to genetic epilepsy and genetic epilepsy syndromes. The detailed specifications within the claims provide a comprehensive framework for utilizing the compound of Formula (I) effectively in the treatment of these conditions, offering potential advancements in the field of neurological disorder management.
To know more about GlobalData’s detailed insights on Praxis Precision Medicines, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
